Hallucinations in Parkinson's disease : A follow-up study
Identifieur interne : 001E33 ( PascalFrancis/Checkpoint ); précédent : 001E32; suivant : 001E34Hallucinations in Parkinson's disease : A follow-up study
Auteurs : Anne Doe De Maindreville [France] ; Gilles Fenelon [France] ; Florence Mahieux [France]Source :
- Movement disorders [ 0885-3185 ] ; 2005.
Descripteurs français
- Pascal (Inist)
English descriptors
Abstract
To study prevalence of hallucinations in patients with Parkinson's disease (PD) during a 1-year period, and identify factors predictive of the onset of hallucinations in patients who were hallucination-free at baseline, 141 unselected outpatients with PD were evaluated prospectively for a set of demographic, clinical, and therapeutic variables and the presence of hallucinations during the previous 3 months. Patient groups were compared with nonparametric tests, and logistic regression was applied to significant data. Follow-up data were available for 127 patients. The hallucination prevalence rates (%) at the first and second evaluation were, respectively, 41.7 and 49.6 for hallucinations of all types (NS), 29.1 and 40.2 for minor hallucinations (i.e., presence or passage hallucinations, and illusions) (P = 0.02), 22.8 and 21.2 for formed visual hallucinations (NS), and 8.7 and 8.7 for auditory hallucinations (NS). Hallucinations rarely started or ceased during the study. The most labile forms were minor hallucinations, which developed in 20% of patients and ceased in 9%. During follow-up, 15% of patients started to hallucinate. Three factors, all present at the first evaluation, independently predicted the onset of hallucinations in patients previously free of hallucinations at baseline (odds ratio; 95% confidence interval): severe sleep disturbances (14.3; 2.5-80.9), ocular disorders (9.1; 1.6-52.0), and a high axial motor score (5.7; 1.2-27.4). Hallucinations have a chronic course in most parkinsonian patients. Factors predicting the onset of hallucinations point to a role of extranigral brainstem involvement and a nonspecific, facilitating role of ocular disorders.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:05-0149709Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Hallucinations in Parkinson's disease : A follow-up study</title><author><name sortKey="Doe De Maindreville, Anne" sort="Doe De Maindreville, Anne" uniqKey="Doe De Maindreville A" first="Anne" last="Doe De Maindreville">Anne Doe De Maindreville</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, Hôpital Maison Blanche</s1><s2>Reims</s2><s3>FRA</s3><sZ>1 aut.</sZ></inist:fA14><country>France</country><placeName><settlement type="city">Reims</settlement></placeName></affiliation></author><author><name sortKey="Fenelon, Gilles" sort="Fenelon, Gilles" uniqKey="Fenelon G" first="Gilles" last="Fenelon">Gilles Fenelon</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Neurologie, Hôpital Henri Mondor (AP-HP)</s1><s2>Créteil</s2><s3>FRA</s3><sZ>2 aut.</sZ></inist:fA14><country>France</country><placeName><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Mahieux, Florence" sort="Mahieux, Florence" uniqKey="Mahieux F" first="Florence" last="Mahieux">Florence Mahieux</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>CEGAP, Hôpital Charles Foix (AP-HP)</s1><s2>Ivry sur Seine</s2><s3>FRA</s3><sZ>3 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>Ivry sur Seine</wicri:noRegion><wicri:noRegion>Hôpital Charles Foix (AP-HP)</wicri:noRegion><wicri:noRegion>Ivry sur Seine</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">05-0149709</idno><date when="2005">2005</date><idno type="stanalyst">PASCAL 05-0149709 INIST</idno><idno type="RBID">Pascal:05-0149709</idno><idno type="wicri:Area/PascalFrancis/Corpus">001F74</idno><idno type="wicri:Area/PascalFrancis/Curation">000D47</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001E33</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Hallucinations in Parkinson's disease : A follow-up study</title><author><name sortKey="Doe De Maindreville, Anne" sort="Doe De Maindreville, Anne" uniqKey="Doe De Maindreville A" first="Anne" last="Doe De Maindreville">Anne Doe De Maindreville</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, Hôpital Maison Blanche</s1><s2>Reims</s2><s3>FRA</s3><sZ>1 aut.</sZ></inist:fA14><country>France</country><placeName><settlement type="city">Reims</settlement></placeName></affiliation></author><author><name sortKey="Fenelon, Gilles" sort="Fenelon, Gilles" uniqKey="Fenelon G" first="Gilles" last="Fenelon">Gilles Fenelon</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Neurologie, Hôpital Henri Mondor (AP-HP)</s1><s2>Créteil</s2><s3>FRA</s3><sZ>2 aut.</sZ></inist:fA14><country>France</country><placeName><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Mahieux, Florence" sort="Mahieux, Florence" uniqKey="Mahieux F" first="Florence" last="Mahieux">Florence Mahieux</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>CEGAP, Hôpital Charles Foix (AP-HP)</s1><s2>Ivry sur Seine</s2><s3>FRA</s3><sZ>3 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>Ivry sur Seine</wicri:noRegion><wicri:noRegion>Hôpital Charles Foix (AP-HP)</wicri:noRegion><wicri:noRegion>Ivry sur Seine</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Follow up study</term><term>Hallucination</term><term>Nervous system diseases</term><term>Parkinson disease</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term><term>Etude longitudinale</term><term>Hallucination</term><term>Parkinson maladie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To study prevalence of hallucinations in patients with Parkinson's disease (PD) during a 1-year period, and identify factors predictive of the onset of hallucinations in patients who were hallucination-free at baseline, 141 unselected outpatients with PD were evaluated prospectively for a set of demographic, clinical, and therapeutic variables and the presence of hallucinations during the previous 3 months. Patient groups were compared with nonparametric tests, and logistic regression was applied to significant data. Follow-up data were available for 127 patients. The hallucination prevalence rates (%) at the first and second evaluation were, respectively, 41.7 and 49.6 for hallucinations of all types (NS), 29.1 and 40.2 for minor hallucinations (i.e., presence or passage hallucinations, and illusions) (P = 0.02), 22.8 and 21.2 for formed visual hallucinations (NS), and 8.7 and 8.7 for auditory hallucinations (NS). Hallucinations rarely started or ceased during the study. The most labile forms were minor hallucinations, which developed in 20% of patients and ceased in 9%. During follow-up, 15% of patients started to hallucinate. Three factors, all present at the first evaluation, independently predicted the onset of hallucinations in patients previously free of hallucinations at baseline (odds ratio; 95% confidence interval): severe sleep disturbances (14.3; 2.5-80.9), ocular disorders (9.1; 1.6-52.0), and a high axial motor score (5.7; 1.2-27.4). Hallucinations have a chronic course in most parkinsonian patients. Factors predicting the onset of hallucinations point to a role of extranigral brainstem involvement and a nonspecific, facilitating role of ocular disorders.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>20</s2></fA05><fA06><s2>2</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Hallucinations in Parkinson's disease : A follow-up study</s1></fA08><fA11 i1="01" i2="1"><s1>DOE DE MAINDREVILLE (Anne)</s1></fA11><fA11 i1="02" i2="1"><s1>FENELON (Gilles)</s1></fA11><fA11 i1="03" i2="1"><s1>MAHIEUX (Florence)</s1></fA11><fA14 i1="01"><s1>Service de Neurologie, Hôpital Maison Blanche</s1><s2>Reims</s2><s3>FRA</s3><sZ>1 aut.</sZ></fA14><fA14 i1="02"><s1>Service de Neurologie, Hôpital Henri Mondor (AP-HP)</s1><s2>Créteil</s2><s3>FRA</s3><sZ>2 aut.</sZ></fA14><fA14 i1="03"><s1>CEGAP, Hôpital Charles Foix (AP-HP)</s1><s2>Ivry sur Seine</s2><s3>FRA</s3><sZ>3 aut.</sZ></fA14><fA20><s1>212-217</s1></fA20><fA21><s1>2005</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20953</s2><s5>354000126378730120</s5></fA43><fA44><s0>0000</s0><s1>© 2005 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>16 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>05-0149709</s0></fA47><fA60><s1>P</s1><s3>CC</s3></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>To study prevalence of hallucinations in patients with Parkinson's disease (PD) during a 1-year period, and identify factors predictive of the onset of hallucinations in patients who were hallucination-free at baseline, 141 unselected outpatients with PD were evaluated prospectively for a set of demographic, clinical, and therapeutic variables and the presence of hallucinations during the previous 3 months. Patient groups were compared with nonparametric tests, and logistic regression was applied to significant data. Follow-up data were available for 127 patients. The hallucination prevalence rates (%) at the first and second evaluation were, respectively, 41.7 and 49.6 for hallucinations of all types (NS), 29.1 and 40.2 for minor hallucinations (i.e., presence or passage hallucinations, and illusions) (P = 0.02), 22.8 and 21.2 for formed visual hallucinations (NS), and 8.7 and 8.7 for auditory hallucinations (NS). Hallucinations rarely started or ceased during the study. The most labile forms were minor hallucinations, which developed in 20% of patients and ceased in 9%. During follow-up, 15% of patients started to hallucinate. Three factors, all present at the first evaluation, independently predicted the onset of hallucinations in patients previously free of hallucinations at baseline (odds ratio; 95% confidence interval): severe sleep disturbances (14.3; 2.5-80.9), ocular disorders (9.1; 1.6-52.0), and a high axial motor score (5.7; 1.2-27.4). Hallucinations have a chronic course in most parkinsonian patients. Factors predicting the onset of hallucinations point to a role of extranigral brainstem involvement and a nonspecific, facilitating role of ocular disorders.</s0></fC01><fC02 i1="01" i2="X"><s0>002B17</s0></fC02><fC02 i1="02" i2="X"><s0>002B17G</s0></fC02><fC02 i1="03" i2="X"><s0>002B17A03</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Etude longitudinale</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Follow up study</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Estudio longitudinal</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Hallucination</s0><s5>04</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Hallucination</s0><s5>04</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Alucinación</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Parkinson maladie</s0><s5>07</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Parkinson disease</s0><s5>07</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Parkinson enfermedad</s0><s5>07</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>40</s5></fC07><fN21><s1>101</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>France</li></country><settlement><li>Créteil</li><li>Reims</li></settlement></list><tree><country name="France"><noRegion><name sortKey="Doe De Maindreville, Anne" sort="Doe De Maindreville, Anne" uniqKey="Doe De Maindreville A" first="Anne" last="Doe De Maindreville">Anne Doe De Maindreville</name></noRegion><name sortKey="Fenelon, Gilles" sort="Fenelon, Gilles" uniqKey="Fenelon G" first="Gilles" last="Fenelon">Gilles Fenelon</name><name sortKey="Mahieux, Florence" sort="Mahieux, Florence" uniqKey="Mahieux F" first="Florence" last="Mahieux">Florence Mahieux</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E33 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 001E33 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:05-0149709
|texte= Hallucinations in Parkinson's disease : A follow-up study
}}
| This area was generated with Dilib version V0.6.23. |  |